Cho Young-Eun, Kim Sang-Hyun, Lee Byung-Heon, Baek Moon-Chang
Department of Molecular Medicine, CMRI, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
Section of Molecular Pharmacology and Toxicology, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD 20892, USA.
Biomol Ther (Seoul). 2017 Jul 1;25(4):367-373. doi: 10.4062/biomolther.2016.174.
This study was performed to evaluate whether microRNAs (miRNAs) in circulating exosomes may serve as biomarkers of drug-induced liver, kidney, or muscle-injury. Quantitative PCR analyses were performed to measure the amounts of liver-specific miRNAs (miR-122, miR-192, and miR-155), kidney-specific miR-146a, or muscle-specific miR-206 in plasma and exosomes from mice treated with liver, kidney or muscle toxicants. The levels of liver-specific miRNAs in circulating plasma and exosomes were elevated in acetaminophen-induced liver injury and returned to basal levels by treatment with antioxidant -acetyl-cysteine. Circulating miR-146a and miR-206 were increased in cisplatin-induced nephrotoxicity and bupivacaine-induced myotoxicity, respectively. Taken together, these results indicate that circulating plasma and exosomal miRNAs can be used as potential biomarkers specific for drug-induced liver, kidney or muscle injury.
本研究旨在评估循环外泌体中的微小RNA(miRNA)是否可作为药物性肝、肾或肌肉损伤的生物标志物。进行定量PCR分析以测量用肝、肾或肌肉毒物处理的小鼠血浆和外泌体中肝脏特异性miRNA(miR-122、miR-192和miR-155)、肾脏特异性miR-146a或肌肉特异性miR-206的量。对乙酰氨基酚诱导的肝损伤中,循环血浆和外泌体中肝脏特异性miRNA水平升高,用抗氧化剂N-乙酰半胱氨酸治疗后恢复至基础水平。顺铂诱导的肾毒性和布比卡因诱导的肌毒性中,循环miR-146a和miR-206分别增加。综上所述,这些结果表明循环血浆和外泌体miRNA可作为药物性肝、肾或肌肉损伤的潜在特异性生物标志物。